A fiducial marker is a medical device that is typically applied to the body or an item to identify the region that needs surgery. This system will locate the precise location of the tumour and assist the doctor in administering the full radiation dose to the tumour while preventing tissue damage. Fiducial markers come in a variety of forms, including metal-based markers, polymer-based markers, and others. They're commonly used in places like the breast, lungs, liver, kidneys, and other organs. Fiducial markers come in a variety of forms, including polymer-based markers and metal-based markers, among others. The fiducial marker technology can also include a 3D image of fiducials as well as a report with the exact diagnosis and treatment plan. These fiducial markers are commonly used in cancer treatments that include radiotherapy.
Request for a sample report: https://whipsmartmi.com/sample/he0503/Fiducial-Markers-Market
Key Driving Factors: Increased use of radiotherapy in cancer care:
The increased use of radiotherapy in cancer treatment has fuelled demand for fiducial markers, assisting the market's growth. Cancer is the second leading cause of death worldwide, according to the World Health Organization, with almost 10 million deaths in 2018. Furthermore, almost 70% of these deaths occur in countries with a low or middle income. However, the rate of occurrence has risen in the developing world as well. Lung and breast cancers are the most common cancers among adults worldwide, with over 4 million cases each. As a result, healthcare institutions and governments are stepping up their efforts to create highly advanced methods to alleviate the burden. Evidence suggests that intensive radiation therapies extend the lives of patients with Stage IV non-small lung cancer who have only a few metastases outside the lungs. Simultaneously, open surgery has been shown to be successful in treating cervical cancers in the early stages. As a result, the market for fiducial markers is growing.
This report offers the major market player’s profiles, such as CIVCO RADIOTHERAPY, Boston Scientific Corporation, IZI Medical Products, IBA, Naslund Medical AB, Medtronic, Best Medical International, Inc., Nanovi A/S, Carbon Medical Technologies, Eckert & Ziegler., Innovative Oncology Solutions, QlRad Inc, Stellar Medical, JJ-MedTech, QFIX, Varian Medical Systems, Inc, Beekley Corporation, Innomedicus Ag, Meditronix Corporation and Seedos Ltd
By End User:
Hospitals and outpatient clinics, independent radiotherapy centres, and cancer research centres are among the end users of fiducial markers. FM positioning around tumours is usually done in outpatient settings seven days before radiotherapy since it is a non-critical treatment. This has ensured a steady market for such facilities' services. Furthermore, the growing use of EBRT procedures (which use FMs for tumour localization) as well as the expansion and modernization of healthcare facilities are boosting this segment's growth.
The Fiducial Markers market report has been categorized as below
By Cancer Type
By End User
Access to Full Report Summary: https://whipsmartmi.com/Report/Fiducial-Markers-Market
Published Date : March-2021